Thrivewell Cancer Foundation is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G32). Contributions are tax-deductible.
4383 Medical Drive 4078, San Antonio, TX 78229-3307
Among the 10 scored disease & disorders organizations in San Antonio, Thrivewell Cancer Foundation holds 4.3 months of operating reserves (peer median 10.2 months), runs a typical yearly deficit of 25.6% (peers: surplus of 7.0%), and has cut spending 10.4% a year (peers: grown spending 12.8% a year).
In fiscal year 2025 it reported $2,829,223 in revenue and $3,456,164 in expenses, with contributions making up 59.1% of revenue.
Thrivewell Cancer Foundation is dedicated to finding a cure for cancer by funding cancer research, providing patient support, and offering programs to improve the quality of life for patients and their families.
Largest programs · fiscal year 2025
Thrivewell Cancer Foundation provides patients with financial assistance to help offset the costs associated with their medical care, as well as treatment related transportation and lodging. The goal of the program is to give patients the best possible chance of beating the disease while eliminating the added stressors that go hand-in-hand with cancer. During 2025 thrivewell's patient assistance p… Read more
Thrivewell Cancer Foundation provides patients with financial assistance to help offset the costs associated with their medical care, as well as treatment related transportation and lodging. The goal of the program is to give patients the best possible chance of beating the disease while eliminating the added stressors that go hand-in-hand with cancer. During 2025 thrivewell's patient assistance program provided lodging, transportation and financial support to 1,763 cancer patients.
$2,445,495 spent · 78.0% of program spending
Thrivewell's diva&dude program provides exercise, nutrition and wellness classes to cancer patients and survivors in San Antonio and bexar county. Research shows that women and men who exercise, follow a healthy diet and adhere to their recommended hormonal or chemotherapy, have a reduction in cancer mortality by up to 50%. As of December 31, 2025, the diva&dude program offered both virtual classe… Read more
Thrivewell's diva&dude program provides exercise, nutrition and wellness classes to cancer patients and survivors in San Antonio and bexar county. Research shows that women and men who exercise, follow a healthy diet and adhere to their recommended hormonal or chemotherapy, have a reduction in cancer mortality by up to 50%. As of December 31, 2025, the diva&dude program offered both virtual classes and 60 in-person classes each week at 8 different locations across San Antonio and bexar county. More than 2,000 women and men are on the diva&dude roster.
$664,461 spent · 21.2% of program spending
THRIVEWELL CANCER FOUNDATION FUNDED TWO CUTTING-EDGE RESEARCH GRANTS IN 2025. Developing an off-the-shelf, supercharging CAR-NKT cell therapy for liver cancer Gang Huang, MD and Targeting lymphotoxin beta receptor to improve immunotherapy of pancreatic cancer - Alexei Tumanov, MD, PhD$25,544 spent · 0.8% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 91¢ went to programs, 5¢ to management and 4¢ to fundraising.
Programs $3,135,500
Management $190,192
Fundraising $130,472
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
91%
Meets
Compared with San Antonio peers
Measure
This organization
Peer median
Operating reserves
4.3 mo
10.2 mo
Typical margin
−25.6%
+7.0%
Spending growth
−10.4% / yr
+12.8% / yr
Debt load
9.8%
6.0%
Peers: the 10 San Antonio disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$2,829,223Fiscal year 2025
Expenses$3,456,164Fiscal year 2025
Total assets$1,373,577Fiscal year 2025
Total liabilities$133,880Fiscal year 2025
Fiscal year ending December2025
Revenue$2,829,223
Expenses$3,456,164
Net income−$626,941
Net assets$1,239,697
Notable sources of revenue
Percent of total revenue
Contributions
$1,670,679
59.1%
Program services
$0
0.0%
Investment income
$48,949
1.7%
Other (net)
$1,109,595
39.2%
Assets / debt
Total assets
$1,373,577
Total liabilities
$133,880
Net assets
$1,239,697
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$3,295,109
Expenses$2,828,386
Net income$466,723
Net assets$1,866,638
Notable sources of revenue
Percent of total revenue
Contributions
$2,428,009
73.7%
Program services
$0
0.0%
Investment income
$61,828
1.9%
Other (net)
$805,272
24.4%
Assets / debt
Total assets
$1,949,435
Total liabilities
$82,797
Net assets
$1,866,638
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$1,752,894
Expenses$2,618,208
Net income−$865,314
Net assets$1,399,915
Notable sources of revenue
Percent of total revenue
Contributions
$899,408
51.3%
Program services
$0
0.0%
Investment income
$30,286
1.7%
Other (net)
$823,200
47.0%
Assets / debt
Total assets
$1,503,953
Total liabilities
$104,038
Net assets
$1,399,915
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$1,377,736
Expenses$4,809,266
Net income−$3,431,530
Net assets$2,265,229
Notable sources of revenue
Percent of total revenue
Contributions
$705,604
51.2%
Program services
$0
0.0%
Investment income
$18,413
1.3%
Other (net)
$653,719
47.4%
Assets / debt
Total assets
$2,357,279
Total liabilities
$92,050
Net assets
$2,265,229
Compensation
Officers and key employees
$125,552
Share of expenses
2.6%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?